Hitting the Bulls AI
The main challenges faced in the field of neurological disorders are that less than 10% of brain scans follow standard guidelines. About 24% of reports contain discrepancies. In clinical measures, the error rate of evaluating disability is about 30%, and 50% of information is not reported. In order to overcome these challenges, icometrix has developed and implemented a value-based care platform for neurological conditions, such as Multiple Sclerosis. The platform integrates AI-driven CE-marked and FDA-cleared technology to ensure that clinically relevant information is of sufficient quality, quantified, and available to the relevant care team member.
This information includes measures from brain MRI or CT scans (increasing consistency of radiological reading by 35%), together with digital measures of cognition, disability, fatigue, depression, etc. A health economic microsimulation study has indicated that software assisted quantified brain MRI measures can improve outcomes and reduce costs in Multiple Sclerosis (Sima et al. 2021).
We collaborate with payers to standardize care, introduce digital health technology for precision medicine of CNS disorders and to assess outcome in value-based arrangements